The Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.
Susan M. Spivey, PharmD, DDS
Advertisement
Articles by Susan M. Spivey, PharmD, DDS
Advertisement
Latest Updated Articles
- Utility of the PhaSeal Closed System Drug Transfer Device
February 1st 2011
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pennsylvania Confirms First Measles Deaths in 35 Years as US Case Count Tops 2900
2
New Lipid Drugs and What Pharmacists Need to Know
3
FDA Approves Ustekinumab Injection for Pediatric Ulcerative Colitis, Expanding IBD Options for Children
4
August 2026 in Oncology: FDA Approvals and Phase 3 Data Reshape Treatment Across Tumor Types
5